Clinical Roundup Targeted radiation during surgery reduces pancreatic cancer recurrence, Hopkins study finds October 31, 2025Vol.51 No.40
Clinical Roundup Drugs approved for pain also reduce bone cancer growth, Hopkins-led pre-clinical study finds October 31, 2025Vol.51 No.40
Clinical Roundup Researchers develop technique to track chemotherapy drug inside cells October 31, 2025Vol.51 No.40
Clinical Roundup Shortened version of HER2 protein may drive treatment resistance in breast cancer, Mayo study finds October 31, 2025Vol.51 No.40
Clinical Roundup Enhancing the body’s “first responder” cells may boost immune therapy, Mayo study finds October 31, 2025Vol.51 No.40
Clinical Roundup Zanzalintinib + atezolizumab improve survival in advanced CRC October 24, 2025Vol.51 No.39
Clinical Roundup Trodelvy reduces risk of disease progression or death by 38% vs. chemo as first-line therapy in metastatic TNBC October 24, 2025Vol.51 No.39
Clinical Roundup Enhertu reduced the risk of disease recurrence or death vs. T-DM1 in high-risk HER2+ early breast cancer following neoadjuvant therapy October 24, 2025Vol.51 No.39
Clinical Roundup Enhertu + THP before surgery resulted in a pathologic complete response in high-risk HER2+ early-stage breast cancer October 24, 2025Vol.51 No.39
